Immunotherapies in the treatment of immunoglobulin E‑mediated allergy: Challenges and scope for innovation (Review)

Zhang P and Lu Q: Genetic and epigenetic influences on the loss of tolerance in autoimmunity. Cell Mol Immunol. 15:575–585. 2018. View Article : Google Scholar

Tulic MK, Hodder M, Forsberg A, McCarthy S, Richman T, D'Vaz N, van den Biggelaar AH, Thornton CA and Prescott SL: Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny. J Allergy Clin Immunol. 127:470–478.e1. 2011. View Article : Google Scholar

Rajan TV: The Gell-Coombs classification of hypersensitivity reactions: A re-interpretation. Trends Immunol. 24:376–379. 2003. View Article : Google Scholar

Passali D, Cingi C, Staffa P, Passali F, Muluk NB and Bellussi ML: The International study of the allergic rhinitis survey: Outcomes from 4 geographical regions. Asia Pac Allergy. 8:e72018. View Article : Google Scholar : PubMed/NCBI

Meltzer EO: Allergic rhinitis: Burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am. 36:235–248. 2016. View Article : Google Scholar : PubMed/NCBI

Pritchard DI, Falcone FH and Mitchell PD: The evolution of IgE-mediated type I hypersensitivity and its immunological value. Allergy. 76:1024–1040. 2021. View Article : Google Scholar : PubMed/NCBI

Cooke RA, Barnard JH, Hebald S and Stull A: Serological evidence of immunity with coexisting sensitization in a type of human allergy (Hay Fever). J Exp Med. 62:733–750. 1935. View Article : Google Scholar : PubMed/NCBI

Worm M, Lee HH, Kleine-Tebbe J, Hafner RP, Laidler P, Healey D, Buhot C, Verhoef A, Maillère B, Kay AB and Larché M: Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. J Allergy Clin Immunol. 127:89–97, 97.e1-14. 2011. View Article : Google Scholar

Bonini S: Regulatory aspects of allergen-specific immunotherapy: Europe sets the scene for a global approach. World Allergy Organ J. 5:120–123. 2012. View Article : Google Scholar : PubMed/NCBI

Gaur SN: Guidelines for allergen immunotherapy in India: 2017-An update. Indian J Allergy Asthma Immunol. 31:1–2. 2017. View Article : Google Scholar

Von Baehr V, Hermes A, Von Baehr R, Scherf HP, Volk HD, Fischer von Weikersthal-Drachenberg KJ and Woroniecki S: Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine. J Investig Allergol Clin Immunol. 15:234–241. 2005.

Hochfelder JL and Ponda P: Allergen immunotherapy: Routes, safety, efficacy, and mode of action. Immunotargets Ther. 2:61–71. 2013.PubMed/NCBI

Chaoul N, Albanesi M, Giliberti L, Rossi MP, Nettis E, Di Bona D, Caiaffa MF and Macchia L: Maintenance-phase subcutaneous immunotherapy with house dust mites induces cyclic immunologic effects. Int Arch Allergy Immunol. 179:37–42. 2019. View Article : Google Scholar

Choi JS, Ryu HR, Yoon CH, Kim JH, Baek JO, Roh JY and Lee JR: Treatment of patients with refractory atopic dermatitis sensitized to house dust mites by using sublingual allergen immunotherapy. Ann Dermatol. 27:82–86. 2015. View Article : Google Scholar

Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, Nelson M, Weber R, Bernstein DI, Blessing-Moore J, et al: Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol. 127 (1 Suppl):S1–S55. 2011. View Article : Google Scholar

Feuille E and Nowak-Wegrzyn A: Allergen-specific immunotherapies for food allergy. Allergy Asthma Immunol Res. 10:189–206. 2018. View Article : Google Scholar : PubMed/NCBI

Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, Norberg LA, Valovirta E, Wahn U, et al: Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 62:943–948. 2007. View Article : Google Scholar : PubMed/NCBI

Pajno GB, Barberio G, De Luca F, Morabito L and Parmiani S: Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 31:1392–1397. 2001. View Article : Google Scholar : PubMed/NCBI

No authors listed. The specific treatment of hay fever. JAMA. 41:1081903.

Noon L: Prophylactic inoculation against hay fever. Lancet. 177:1572–1573. 1911. View Article : Google Scholar

Black JH: The oral administration of pollen: A clinical report. J Lab Clin Med. 13:709–713. 1928.

Mackenzie GM and Baldwin LB: Local desensitization in hypersensitive individuals and its bearing on the prevention of hay-fever. Arch Intern Med (Chic). 28:722–732. 1921. View Article : Google Scholar

Scadding GK and Brostoff J: Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy. 16:483–491. 1986. View Article : Google Scholar : PubMed/NCBI

Senti G, Prinz Vavricka BM, Erdmann I, Diaz MI, Markus R, McCormack SJ, Simard JJ, Wüthrich B, Crameri R, Graf N, et al: Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial. Proc Natl Acad Sci USA. 105:17908–17912. 2008. View Article : Google Scholar : PubMed/NCBI

Stanworth DR: The discovery of IgE. Allergy. 48:67–71. 1993. View Article : Google Scholar : PubMed/NCBI

Lichtenstein LM, Holtzman NA and Burnett LS: A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J Immunol. 101:317–324. 1968.

Marsh DG, Lichtenstein LM and Campbell DH: Studies on ‘allergoids’ prepared from naturally occurring allergens: I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology. 18:705–722. 1970.PubMed/NCBI

Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P, Reisinger J, Pelzmann M, Hayek B, Kronqvist M, et al: Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci USA. 101 (Suppl 2):S14677–S14682. 2004. View Article : Google Scholar

Kouser L, Kappen J, Walton RP and Shamji MH: Update on biomarkers to monitor clinical efficacy response during and post treatment in allergen immunotherapy. Curr Treat Options Allergy. 4:43–53. 2017. View Article : Google Scholar : PubMed/NCBI

Bachmann MF and Kündig TM: Allergen-specific immunotherapy: Is it vaccination against toxins after all? Allergy. 72:13–23. 2017. View Article : Google Scholar : PubMed/NCBI

Esch RE: Allergen source materials and quality control of allergenic extracts. Methods. 13:2–13. 1997. View Article : Google Scholar : PubMed/NCBI

Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H and Cromwell O: Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 116:608–613. 2005. View Article : Google Scholar

Grier TJ: How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations. Ann Allergy Asthma Immunol. 108:201–205. 2012. View Article : Google Scholar

Ferreira F, Briza P, Infuhr D, Schmidt G, Wallner M, Wopfner N, Thalhamer J and Achatz G: Modified recombinant allergens for safer immunotherapy. Inflamm Allergy Drug Targets. 5:5–14. 2006. View Article : Google Scholar : PubMed/NCBI

Jaye T: Allergy immunotherapy update. Curr Allergy Clin Immunol. 32:91–94. 2019.

Spiric J, Reuter A and Rabin R: Mass spectrometry to complement standardization of house dust mite and other complex allergenic extracts. Clin Exp Allergy. 47:604–617. 2017. View Article : Google Scholar : PubMed/NCBI

Köberlein J and Mösges R: Oralair(^®): A causal treatment for grass pollen-induced allergic rhinoconjunctivitis. Immunotherapy. 5:13–21. 2013. View Article : Google Scholar

Dougherty JA, Wagner JD and Stanton MC: Peanut allergen powder-dnfp: A novel oral immunotherapy to mitigate peanut allergy. Ann Pharmacother. 55:344–353. 2021. View Article : Google Scholar : PubMed/NCBI

Zuidmeer-Jongejan L, Huber H, Swoboda I, Rigby N, Versteeg SA, Jensen BM, Quaak S, Akkerdaas JH, Blom L, Asturias J, et al: Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy. Int Arch Allergy Immunol. 166:41–51. 2015. View Article : Google Scholar

Rizvi AY and Panchal AS: Timothy grass pollen allergen extract (Grastek) for allergic rhinitis. Am Fam Physician. 92:1096–1097. 2015.PubMed/NCBI

Cho SW, Han DH, Kim JW, Kim DY and Rhee CS: House dust mite sublingual immunotherapy in allergic rhinitis. Immunotherapy. 10:567–578. 2018. View Article : Google Scholar : PubMed/NCBI

Nelson HS: Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek^®) for the treatment of allergic rhinitis. Expert Rev Clin Immunol. 14:1003–1011. 2018. View Article : Google Scholar

Erlich D: Peanut allergen powder (Palforzia) for peanut allergy. Am Fam Physician. 105:20–21. 2022.PubMed/NCBI

Thompson CP, Silvers S and Shapiro MA: Intralymphatic immunotherapy for mountain cedar pollinosis: A randomized, double-blind, placebo-controlled trial. Ann Allergy Asthma Immunol. 125:311–318.e2. 2020. View Article : Google Scholar

Senti G, von Moos S, Tay F, Graf N, Sonderegger T, Johansen P and Kündig TM: Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol. 129:128–135. 2012. View Article : Google Scholar

Gaur SN: Allergoid preparations for allergen immunotherapy: A brief overview. Indian J Allergy Asthma Immunol. 32:1–3. 2018. View Article : Google Scholar

Carnes J, Gallego MT, Moya R and Iraola V: Allergoids for allergy treatment. Recent Pat Inflamm Allergy Drug Discov. 12:110–119. 2018. View Article : Google Scholar : PubMed/NCBI

Focke-Tejkl M and Valenta R: Safety of engineered allergen-specific immunotherapy vaccines. Curr Opin Allergy Clin Immunol. 12:555–563. 2012. View Article : Google Scholar

Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, Pfister T, Maurer P, Bachmann MF, Graf N and Kündig TM: Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: A phase I/IIa clinical trial. Clin Exp Allergy. 39:562–570. 2009. View Article : Google Scholar : PubMed/NCBI

Satitsuksanoa P, Globinska A, Jansen K, van de Veen W and Akdis M: Modified allergens for immunotherapy. Curr Allergy Asthma Rep. 18:92018. View Article : Google Scholar : PubMed/NCBI

Akdis CA and Blaser K: Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol. 121:261–269. 2000. View Article : Google Scholar

Singh N, Bhatia S, Abraham R, Basu SK, George A, Bal V and Rath S: Modulation of T cell cytokine profiles and peptide-MHC complex availability in vivo by delivery to scavenger receptors via antigen maleylation. J Immunol. 160:4869–4880. 1998.

Bhatia S, Mukhopadhyay S, Jarman E, Hall G, George A, Basu SK, Rath S, Lamb JR and Bal V: Scavenger receptor-specific allergen delivery elicits IFN-gamma-dominated immunity and directs established TH2-dominated responses to a nonallergic phenotype. J Allergy Clin Immunol. 109:321–328. 2002. View Article : Google Scholar

Tighe H, Takabayashi K, Schwartz D, Marsden R, Beck L, Corbeil J, Richman DD, Eiden JJ Jr, Spiegelberg HL and Raz E: Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity. Eur J Immunol. 30:1939–1947. 2000. View Article : Google Scholar

Takai T, Mori A, Yuuki T, Okudaira H and Okumura Y: Non-anaphylactic combination of partially deleted fragments of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Mol Immunol. 36:1055–1065. 1999. View Article : Google Scholar

Swoboda I, de Weerd N, Bhalla PL, Niederberger V, Sperr WR, Valent P, Kahlert H, Fiebig H, Ebner C, Spitzauer S, et al: Hypoallergenic forms of the ryegrass pollen allergen Lol p 5 as candidates for immunotherapy. Int Arch Allergy Immunol. 124:380–382. 2001. View Article : Google Scholar

Wu CH, Lee MF, Yang JS and Tseng CY: IgE-binding epitopes of the American cockroach Per a 1 allergen. Mol Immunol. 39:459–464. 2002. View Article : Google Scholar

Kücüksezer UC, Palomares O, Rückert B, Jartti T, Puhakka T, Nandy A, Gemicioğlu B, Fahrner HB, Jung A, Deniz G, et al: Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol. 131:875–885. 2013. View Article : Google Scholar

Li L and Boussiotis V: Control and regulation of peripheral tolerance in allergic inflammatory disease: Therapeutic consequences. Chem Immunol Allergy. 94:178–188. 2008. View Article : Google Scholar : PubMed/NCBI

Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH and Umetsu DT: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med. 8:1024–1032. 2002. View Article : Google Scholar : PubMed/NCBI

Legoux FP, Lim JB, Cauley AW, Dikiy S, Ertelt J, Mariani TJ, Sparwasser T, Way SS and Moon JJ: CD4+ T cell tolerance to tissue-restricted self antigens is mediated by antigen-specific regulatory T cells rather than deletion. Immunity. 43:896–908. 2015. View Article : Google Scholar : PubMed/NCBI

Soroosh P, Doherty TA, Duan W, Mehta AK, Choi H, Adams YF, Mikulski Z, Khorram N, Rosenthal P, Broide DH and Croft M: Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J Exp Med. 210:775–788. 2013. View Article : Google Scholar : PubMed/NCBI

Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR and Belkaid Y: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med. 204:1775–1785. 2007. View Article : Google Scholar : PubMed/NCBI

Akdis CA and Akdis M: Advances in allergen immunotherapy: Aiming for complete tolerance to allergens. Sci Transl Med. 7:280ps2862015. View Article : Google Scholar

Smarr CB, Bryce PJ and Miller SD: Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Crit Rev Immunol. 33:389–414. 2013. View Article : Google Scholar

Akkoc T, Akdis M and Akdis CA: Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res. 3:11–20. 2011. View Article : Google Scholar : PubMed/NCBI

Larché M, Akdis CA and Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 6:761–771. 2006. View Article : Google Scholar

Hughes CE, Benson RA, Bedaj M and Maffia P: Antigen-presenting cells and antigen presentation in tertiary lymphoid organs. Front Immunol. 7:4812016. View Article : Google Scholar

Janeway Jr CA, Travers P, Walport M and Shlomchik MJ: Principles of innate and adaptive immunity. Immunobiology: The Immune System in Health and Disease. 5th edition. Garland Science; New York: pp. 13–25. 2001

Kappen JH, Durham SR, Veen HI and Shamji MH: Applications and mechanisms of immunotherapy in allergic rhinitis and asthma. Ther Adv Respir Dis. 11:73–86. 2017. View Article : Google Scholar : PubMed/NCBI

Lawrence MG, Steinke JW and Borish L: Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy. Ann Allergy Asthma Immunol. 117:138–142. 2016. View Article : Google Scholar

Chang K, Song JY and Lim DS: Tolerogenic dendritic cell-based immunotherapy. Oncotarget. 8:90630–90631. 2017. View Article : Google Scholar

Choo EH, Lee JH, Park EH, Park HE, Jung NC, Kim TH, Koh YS, Kim E, Seung KB, Park C, et al: Infarcted myocardium-primed dendritic cells improve remodeling and cardiac function after myocardial infarction by modulating the regulatory T cell and macrophage polarization. Circulation. 135:1444–1457. 2017. View Article : Google Scholar : PubMed/NCBI

Lee JH, Kim TH, Park HE, Lee EG, Jung NC, Song JY, Seo HG, Seung KB, Chang K and Lim DS: Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis. Cardiovasc Res. 101:203–210. 2014. View Article : Google Scholar : PubMed/NCBI

Allam JP, Würtzen PA, Reinartz M, Winter J, Vrtala S, Chen KW, Valenta R, Wenghoefer M, Appel T, Gros E, et al: Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. J Allergy Clin Immunol. 126:638–645.e1. 2010. View Article : Google Scholar

Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H, Betbeder D, Balazuc AM, Van Overtvelt L and Moingeon P: Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J Allergy Clin Immunol. 122:603–609.e5. 2008. View Article : Google Scholar

Morianos I and Semitekolou M: Dendritic cells: Critical regulators of allergic asthma. Int J Mol Sci. 21:79302020. View Article : Google Scholar

Reuter S, Lemmermann NAW, Maxeiner J, Podlech J, Beckert H, Freitag K, Teschner D, Ries F, Taube C, Buhl R, et al: Coincident airway exposure to low-potency allergen and cytomegalovirus sensitizes for allergic airway disease by viral activation of migratory dendritic cells. PLoS Pathog. 15:e10075952019. View Article : Google Scholar : PubMed/NCBI

Zakeri A and Russo M: Dual role of Toll-like Receptors in human and experimental asthma models. Front Immunol. 9:10272018. View Article : Google Scholar

Manicassamy S and Pulendran B: Dendritic cell control of tolerogenic responses. Immunol Rev. 241:206–227. 2011. View Article : Google Scholar : PubMed/NCBI

Ray A, Khare A, Krishnamoorthy N, Qi Z and Ray P: Regulatory T cells in many flavors control asthma. Mucosal Immunol. 3:216–229. 2010. View Article : Google Scholar

Akdis CA and Akdis M: Mechanisms of immune tolerance to allergens: Role of IL-10 and Tregs. J Clin Invest. 124:4678–4680. 2014. View Article : Google Scholar

Shamji MH, Layhadi JA, Achkova D, Kouser L, Perera-Webb A, Couto-Francisco NC, Parkin RV, Matsuoka T, Scadding G, Ashton-Rickardt PG and Durham SR: Role of IL-35 in sublingual allergen immunotherapy. J Allergy Clin Immunol. 143:1131–1142.e4. 2019. View Article : Google Scholar

Fujita H, Soyka MB, Akdis M and Akdis CA: Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy. 2:22012. View Article : Google Scholar : PubMed/NCBI

Jeannin P, Lecoanet S, Delneste Y, Gauchat JF and Bonnefoy JY: IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 160:3555–3561. 1998.

Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K and Akdis CA: IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 33:1205–1214. 2003. View Article : Google Scholar

Quakyi IA and Ahlers JD: Assessing CD4+ helper T-lymphocyte responses by lymphoproliferation. Methods Mol Med. 72:369–383. 2002.PubMed/NCBI

Gorelik L, Fields PE and Flavell RA: Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol. 165:4773–4777. 2000. View Article : Google Scholar

Heath VL, Murphy EE, Crain C, Tomlinson MG and O'Garra A: TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol. 30:2639–2649. 2000. View Article : Google Scholar

Nakamura T and Ushigome H: Myeloid-derived suppressor cells as a regulator of immunity in organ transplantation. Int J Mol Sci. 19:23572018. View Article : Google Scholar

Chekol Abebe E, Asmamaw Dejenie T, Mengie Ayele T, Dagnew Baye N, Agegnehu Teshome A and Tilahun Muche Z: The role of regulatory B cells in health and diseases: A systemic review. J Inflamm Res. 14:75–84. 2021. View Article : Google Scholar : PubMed/NCBI

Katz SI, Parker D and Turk JL: B-cell suppression of delayed hypersensitivity reactions. Nature. 251:550–551. 1974. View Article : Google Scholar : PubMed/NCBI

van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Söllner S, Akdis DG, Rückert B, Akdis CA and Akdis M: IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 131:1204–1212. 2013. View Article : Google Scholar

Lee KM, Stott RT, Zhao G, SooHoo J, Xiong W, Lian MM, Fitzgerald L, Shi S, Akrawi E, Lei J, et al: TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol. 44:1728–1736. 2014. View Article : Google Scholar

Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, Ries S, Dang VD, Jaimes Y, Daridon C, et al: IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 507:366–370. 2014. View Article : Google Scholar : PubMed/NCBI

Carter NA, Rosser EC and Mauri C: IL-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of Tr1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther. 14:R322012. View Article : Google Scholar : PubMed/NCBI

Das A, Ellis G, Pallant C, Lopes AR, Khanna P, Peppa D, Chen A, Blair P, Dusheiko G, Gill U, et al: IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol. 189:3925–3935. 2012. View Article : Google Scholar

Mauri C and Menon M: The expanding family of regulatory B cells. Int Immunol. 27:479–486. 2015. View Article : Google Scholar

Zaimoku Y, Patel BA, Kajigaya S, Feng X, Alemu L, Quinones Raffo D, Groarke EM and Young NS: Deficit of circulating CD19⁺ CD24^hi CD38^hi regulatory B cells in severe aplastic anaemia. Br J Haematol. 190:610–617. 2020. View Article : Google Scholar

Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR and Mauri C: CD19+ CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 32:129–140. 2010. View Article : Google Scholar : PubMed/NCBI

Khoder A, Sarvaria A, Alsuliman A, Chew C, Sekine T, Cooper N, Mielke S, de Lavallade H, Muftuoglu M, Fernandez Curbelo I, et al: Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Blood. 124:2034–2045. 2014. View Article : Google Scholar : PubMed/NCBI

Kim AS, Doherty TA, Karta MR, Das S, Baum R, Rosenthal P, Beppu A, Miller M, Kurten R and Broide DH: Regulatory B cells and T follicular helper cells are reduced in allergic rhinitis. J Allergy Clin Immunol. 138:1192–1195.e5. 2016. View Article : Google Scholar

Luo J, Guo H, Liu Z, Peng T, Hu X, Han M, Yang X, Zhou X and Li H: Analysis of peripheral B cell subsets in patients with allergic rhinitis. Allergy Asthma Immunol Res. 10:236–243. 2018. View Article : Google Scholar : PubMed/NCBI

Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A and Fallon PG: Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 125:1114–1124.e8. 2010. View Article : Google Scholar

Kanagaratham C, El Ansari YS, Lewis OL and Oettgen HC: IgE and IgG antibodies as regulators of mast cell and basophil functions in food allergy. Front Immunol. 11:6030502020. View Article : Google Scholar

Santos AF, James LK, Bahnson HT, Shamji MH, Couto-Francisco NC, Islam S, Houghton S, Clark AT, Stephens A, Turcanu V, et al: IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens. J Allergy Clin Immunol. 135:1249–1256. 2015. View Article : Google Scholar

James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, Jacobson MR, Kimber I, Till SJ and Durham SR: Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol. 127:509–516.e1-e5. 2011. View Article : Google Scholar

Hassan G, Kant S, Prakash V, Verma AK, Saheer S, Singh A, Singh A, Jena NN and Wani NA: Allergen immunotherapy: Basic concepts. Indian J Allergy Asthma Immunol. 27:9–18. 2013. View Article : Google Scholar

Aricigil M, Muluk NB, Sakarya EU, Sakalar EG, Senturk M, Reisacher WR and Cingi C: New routes of allergen immunotherapy. Am J Rhinol Allergy. 30:193–197. 2016. View Article : Google Scholar : PubMed/NCBI

Di Bona D, Plaia A, Leto-Barone MS, La Piana S and Di Lorenzo G: Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis-based comparison. J Allergy Clin Immunol. 130:1097–1107.e2. 2012. View Article : Google Scholar

Cox L, Calderon M and Pfaar O: Subcutaneous allergen immunotherapy for allergic disease: Examining efficacy, safety and cost-effectiveness of current and novel formulations. Immunotherapy. 4:601–616. 2012. View Article : Google Scholar : PubMed/NCBI

Krishna MT and Huissoon AP: Clinical immunology review series: An approach to desensitization. Clin Exp Immunol. 163:131–146. 2011. View Article : Google Scholar

Bergmann KC and Ring J: History of Allergy. Vol 100. Karger Medical and Scientific Publishers; Switzerland: 2014

Hesse L, Brouwer U, Petersen AH, Gras R, Bosman L, Brimnes J, Oude Elberink JNG, van Oosterhout AJM and Nawijn MC: Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. Clin Exp Allergy. 48:1035–1049. 2018. View Article : Google Scholar : PubMed/NCBI

Jacobsen L, Wahn U and Bilo MB: Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: The effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy. 2:82012. View Article : Google Scholar : PubMed/NCBI

Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, et al: Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: The GRASS randomized clinical trial. JAMA. 317:615–625. 2017. View Article : Google Scholar : PubMed/NCBI

Jongkhajornpong P and Laisuan W: Successful subcutaneous allergen-specific immunotherapy in refractory atopic keratoconjunctivitis: A case report. Case Rep Ophthalmol. 8:562–567. 2017. View Article : Google Scholar

Aasbjerg K, Backer V, Lund G, Holm J, Nielsen NC, Holse M, Wagtmann VR and Würtzen PA: Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy. Clin Exp Allergy. 44:417–428. 2014. View Article : Google Scholar : PubMed/NCBI

Schülke S: Induction of Interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses. Front Immunol. 9:4552018. View Article : Google Scholar

Bellinghausen I, König B, Böttcher I, Knop J and Saloga J: Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Clin Exp Allergy. 36:1546–1555. 2006. View Article : Google Scholar

Taylor A, Verhagen J, Blaser K, Akdis M and Akdis CA: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: The role of T regulatory cells. Immunology. 117:433–442. 2006. View Article : Google Scholar : PubMed/NCBI

Maggi E: T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol. 161:10–18. 2010. View Article : Google Scholar

Sousa L, Martín-Sierra C, Pereira C, Loureiro G, Tavares B, Pedreiro S, Martinho A and Paiva A: Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients. Allergy Asthma Clin Immunol. 14:452018. View Article : Google Scholar

Lao-Araya M, Steveling E, Scadding GW, Durham SR and Shamji MH: Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol. 134:1193–1195. e42014. View Article : Google Scholar

Halim TY, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG and McKenzie AN: Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol. 17:57–64. 2016. View Article : Google Scholar

Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J, Friedrichs F, Fuchs T, Gieler U, Jakob T, et al: Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German society for allergology and clinical immunology (DGAKI), the association of German allergologists (AeDA), the society of pediatric allergy and environmental medicine (GPA), the German academy of allergology and environmental medicine (DAAU), the German professional association of pediatricians (BVKJ), the Austrian society for allergology and immunology (ÖGAI), the Swiss society for allergy and immunology (SGAI), the German society of anaesthesiology and intensive care medicine (DGAI), the German society of pharmacology (DGP), the German society for psychosomatic medicine (DGPM), the German working group of anaphylaxis training and education (AGATE) and the patient organization German allergy and asthma association (DAAB). Allergo J Int. 23:96–112. 2014. View Article : Google Scholar

Okamoto Y, Fujieda S, Okano M, Yoshida Y, Kakudo S and Masuyama K: House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis. Allergy. 72:435–443. 2017. View Article : Google Scholar : PubMed/NCBI

Lim JH, Kim JY, Han DH, Lee CH, Hong SN, Wee JH, Park SK and Rhee CS: Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children. PLoS One. 12:e01822952017. View Article : Google Scholar : PubMed/NCBI

Frati F, Scurati S, Puccinelli P, David M, Hilaire C, Capecce M, Marcucci F and Incorvaia C: Development of a sublingual allergy vaccine for grass pollinosis. Drug Des Devel Ther. 4:99–105. 2010.PubMed/NCBI

Calderon MA, Penagos M, Sheikh A, Canonica GW and Durham SR: Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis. Clin Exp Allergy. 41:1263–1272. 2011. View Article : Google Scholar : PubMed/NCBI

Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J and Novak N: Distribution of Langerhans cells and mast cells within the human oral mucosa: New application sites of allergens in sublingual immunotherapy? Allergy. 63:720–727. 2008. View Article : Google Scholar : PubMed/NCBI

Schulten V, Tripple V, Aasbjerg K, Backer V, Lund G, Würtzen PA, Sette A and Peters B: Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy. Clin Exp Allergy. 46:439–448. 2016. View Article : Google Scholar : PubMed/NCBI

Larche M: Immune mechanisms of sublingual immunotherapy: Are oral Langerhans cells the masters of tolerance? J Allergy Clin Immunol. 126:646–647. 2010. View Article : Google Scholar

Allam JP, Novak N, Fuchs C, Asen S, Bergé S, Appel T, Geiger E, Kochan JP and Bieber T: Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol. 112:141–148. 2003. View Article : Google Scholar

Moingeon P, Lombardi V, Baron-Bodo V and Mascarell L: Enhancing allergen-presentation platforms for sublingual immunotherapy. J Allergy Clin Immunol Pract. 5:23–31. 2017. View Article : Google Scholar

Francis JN, Till SJ and Durham SR: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 111:1255–1261. 2003. View Article : Google Scholar

Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B and Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol. 120:707–713. 2007. View Article : Google Scholar

Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, Bousquet J, Calderón M, Compalati E, Durham SR, et al: Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J. 7:62014. View Article : Google Scholar : PubMed/NCBI

Fiocchi A, Pajno G, La Grutta S, Pezzuto F, Incorvaia C, Sensi L, Marcucci F and Frati F: Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol. 95:254–258. 2005. View Article : Google Scholar

Saporta D: Sublingual immunotherapy: A useful tool for the allergist in private practice. Biomed Res Int. 2016:93238042016. View Article : Google Scholar

Feuille E and Nowak-Węgrzyn A: Oral immunotherapy for food allergies. Ann Nutr Metab. 68 (Suppl 1):S19–S31. 2016. View Article : Google Scholar

Wang YT, Liu HC, Chen HC, Lee YC, Tsai TC, Chen HL, Fan HC and Chen CM: Oral immunotherapy with the ingestion of house dust mite extract in a murine model of allergic asthma. Allergy Asthma Clin Immunol. 14:432018. View Article : Google Scholar

Khoriaty E and Umetsu DT: Oral immunotherapy for food allergy: Towards a new horizon. Allergy Asthma Immunol Res. 5:3–15. 2013. View Article : Google Scholar : PubMed/NCBI

Pandiyan P, Bhaskaran N, Zou M, Schneider E, Jayaraman S and Huehn J: Microbiome dependent regulation of T_regs and Th17 cells in Mucosa. Front Immunol. 10:4262019. View Article : Google Scholar

Faria AM and Weiner HL: Oral tolerance: Mechanisms and therapeutic applications. Adv Immunol. 73:153–264. 1999. View Article : Google Scholar

Smaldini PL, Orsini Delgado ML, Fossati CA and Docena GH: Orally-induced intestinal CD4+ CD25+ FoxP3+ Treg controlled undesired responses towards oral antigens and effectively dampened food allergic reactions. PLoS One. 10:e01411162015. View Article : Google Scholar : PubMed/NCBI

Mizrahi M and Ilan Y: The gut mucosa as a site for induction of regulatory T-cells. Curr Pharm Des. 15:1191–1202. 2009. View Article : Google Scholar : PubMed/NCBI

Vickery BP, Lin J, Kulis M, Fu Z, Steele PH, Jones SM, Scurlock AM, Gimenez G, Bardina L, Sampson HA and Burks AW: Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol. 131:128–134.e1-3. 2013. View Article : Google Scholar

Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, et al: Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 133:468–475. 2014. View Article : Google Scholar

Sampson HA: Peanut oral immunotherapy: Is it ready for clinical practice? J Allergy Clin Immunol Pract. 1:15–21. 2013. View Article : Google Scholar

Chu DK, Wood RA, French S, Fiocchi A, Jordana M, Waserman S, Brożek JL and Schünemann HJ: Oral immunotherapy for peanut allergy (PACE): A systematic review and meta-analysis of efficacy and safety. Lancet. 393:2222–2232. 2019. View Article : Google Scholar

Anagnostou A: Weighing the benefits and risks of oral immunotherapy in clinical practice. Allergy Asthma Proc. 42:118–123. 2021. View Article : Google Scholar

Dioszeghy V, Mondoulet L, Laoubi L, Dhelft V, Plaquet C, Bouzereau A, Dupont C and Sampson H: Antigen uptake by langerhans cells is required for the induction of regulatory T cells and the acquisition of tolerance during epicutaneous immunotherapy in OVA-sensitized mice. Front Immunol. 9:19512018. View Article : Google Scholar

Senti G, von Moos S and Kündig TM: Epicutaneous immunotherapy for aeroallergen and food allergy. Curr Treat Options Allergy. 1:68–78. 2014. View Article : Google Scholar : PubMed/NCBI

Gorfu G, Rivera-Nieves J and Ley K: Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med. 9:836–850. 2009. View Article : Google Scholar : PubMed/NCBI

Yu LC: Intestinal epithelial barrier dysfunction in food hypersensitivity. J Allergy (Cairo). 2012:5960812012.PubMed/NCBI

Tordesillas L, Mondoulet L, Blazquez AB, Benhamou PH, Sampson HA and Berin MC: Epicutaneous immunotherapy induces gastrointestinal LAP⁺ regulatory T cells and prevents food-induced anaphylaxis. J Allergy Clin Immunol. 139:189–201.e4. 2017. View Article : Google Scholar

Plunkett CH and Nagler CR: The influence of the microbiome on allergic sensitization to food. J Immunol. 198:581–589. 2017. View Article : Google Scholar

Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Dupont C and Benhamou PH: Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy. 40:659–667. 2010. View Article : Google Scholar : PubMed/NCBI

Mondoulet L, Dioszeghy V, Puteaux E, Ligouis M, Dhelft V, Letourneur F, Dupont C and Benhamou PH: Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice. Clin Transl Allergy. 2:222012. View Article : Google Scholar : PubMed/NCBI

Dupont C, Kalach N, Soulaines P, Legoué-Morillon S, Piloquet H and Benhamou PH: Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol. 125:1165–1167. 2010. View Article : Google Scholar

Senti G, Johansen P and Kundig TM: Intralymphatic immunotherapy. Curr Opin Allergy Clin Immunol. 9:537–543. 2009. View Article : Google Scholar

Hylander T, Latif L, Petersson-Westin U and Cardell LO: Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis. J Allergy Clin Immunol. 131:412–420. 2013. View Article : Google Scholar

Kim ST, Park SH, Lee SM and Lee SP: Allergen-specific intralymphatic immunotherapy in human and animal studies. Asia Pac Allergy. 7:131–137. 2017. View Article : Google Scholar : PubMed/NCBI

Senti G, Freiburghaus AU, Larenas-Linnemann D, Hoffmann HJ, Patterson AM, Klimek L, Di Bona D, Pfaar O, Ahlbeck L, Akdis M, et al: Intralymphatic immunotherapy: Update and unmet needs. Int Arch Allergy Immunol. 178:141–149. 2019. View Article : Google Scholar

Martínez-Gómez JM, Johansen P, Erdmann I, Senti G, Crameri R and Kündig TM: Intralymphatic injections as a new administration route for allergen-specific immunotherapy. Int Arch Allergy Immunol. 150:59–65. 2009. View Article : Google Scholar

Freiberger SN, Zehnder M, Gafvelin G, Gronlund H, Kundig TM and Johansen P: IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human. Allergy. 71:1366–1370. 2016. View Article : Google Scholar : PubMed/NCBI

Konradsen JR, Grundström J, Hellkvist L, Tran TAT, Andersson N, Gafvelin G, Kiewiet MBG, Hamsten C, Tang J, Parkin RV, et al: Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial. J Allergy Clin Immunol. 145:1005–1007.e7. 2020. View Article : Google Scholar

Rajakulendran M, Tham EH, Soh JY and Van Bever HP: Novel strategies in immunotherapy for allergic diseases. Asia Pac Allergy. 8:e142018. View Article : Google Scholar : PubMed/NCBI

Fischer N, Rostaher A and Favrot C: Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis. Schweiz Arch Tierheilkd. 158:646–652. 2016.(In German). View Article : Google Scholar : PubMed/NCBI

Nelson MR and Cox L: Allergen immunotherapy extract preparation manual. Practice Management Resource Guide. 2014 edition. American Academy of Allergy, Asthma & Immunology; pp. 1–30. 2014

Nony E, Martelet A, Jain K and Moingeon P: Allergen extracts for immunotherapy: To mix or not to mix? Expert Rev Clin Pharmacol. 9:401–408. 2016. View Article : Google Scholar

Helyeh S, David L and Gary S: Advances in the management of food allergy in children. Curr Pediatr Rev. 14:150–155. 2018. View Article : Google Scholar : PubMed/NCBI

Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, Beyer K, Bindslev-Jensen C, Burks W, Ebisawa M, et al: EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 73:799–815. 2018. View Article : Google Scholar : PubMed/NCBI

Pfaar O, Alvaro M, Cardona V, Hamelmann E, Mosges R and Kleine-Tebbe J: Clinical trials in allergen immunotherapy: Current concepts and future needs. Allergy. 73:1775–1783. 2018. View Article : Google Scholar : PubMed/NCBI

Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, Friedrichs F, Fuchs T, Hamelmann E, Hartwig-Bade D, et al: Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k guideline of the German society for allergology and clinical immunology (DGAKI), the society for pediatric allergy and environmental medicine (GPA), the medical association of German allergologists (AeDA), the Austrian society for allergy and immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German society of pediatrics and adolescent medicine (DGKJ), the society for pediatric pneumology (GPP), the German respiratory society (DGP), the German association of ENT surgeons (BV-HNO), the professional federation of paediatricians and youth doctors (BVKJ), the federal association of pulmonologists (BDP) and the German dermatologists association (BVDD). Allergo J Int. 23:282–319. 2014. View Article : Google Scholar

Halken S, Larenas-Linnemann D, Roberts G, Calderón MA, Angier E, Pfaar O, Ryan D, Agache I, Ansotegui IJ, Arasi S, et al: EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol. 28:728–745. 2017. View Article : Google Scholar

Globinska A, Boonpiyathad T, Satitsuksanoa P, Kleuskens M, van de Veen W, Sokolowska M and Akdis M: Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens. Ann Allergy Asthma Immunol. 121:306–312. 2018. View Article : Google Scholar

Chen J, Zhou Y, Wang Y, Zheng Y, Lai X, Westermann-Clark E, Cho SH and Kong W: Specific immunoglobulin E and immunoglobulin G4 toward major allergens of house-dust mite during allergen-specific immunotherapy. Am J Rhinol Allergy. 31:156–160. 2017. View Article : Google Scholar : PubMed/NCBI

Ciprandi G, Tosca MA and Silvestri M: The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy. Expert Rev Clin Immunol. 10:321–324. 2014. View Article : Google Scholar

Palomares O, Martin-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M and Akdis CA: Regulatory T cells and immune regulation of allergic diseases: Roles of IL-10 and TGF-beta. Genes Immun. 15:511–520. 2014. View Article : Google Scholar : PubMed/NCBI

Licari A, Castagnoli R, Brambilla I, Tosca MA, De Filippo M, Marseglia G and Ciprandi G: Biomarkers of immunotherapy response in patients with allergic rhinitis. Expert Rev Clin Immunol. 14:657–663. 2018. View Article : Google Scholar

Gueguen C, Bouley J, Moussu H, Luce S, Duchateau M, Chamot-Rooke J, Pallardy M, Lombardi V, Nony E, Baron-Bodo V, et al: Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy. J Allergy Clin Immunol. 137:545–558. 2016. View Article : Google Scholar

Caruso M, Cibella F, Emma R, Campagna D, Tringali G, Amaradio MD and Polosa R: Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis. Int Immunopharmacol. 60:50–58. 2018. View Article : Google Scholar

Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, Azar A, Baroody FM, Bachert C, Canonica GW, et al: International consensus statement on allergy and rhinology: Allergic rhinitis. Int Forum Allergy Rhinol. 8:108–352. 2018. View Article : Google Scholar

Demoly P, Passalacqua G, Pfaar O, Sastre J and Wahn U: Management of the polyallergic patient with allergy immunotherapy: A practice-based approach. Allergy Asthma Clin Immunol. 12:22016. View Article : Google Scholar

Ciprandi G, Alesina R, Ariano R, Aurnia P, Borrelli P, Cadario G, Capristo A, Carosso A, Casino G, Castiglioni G, et al: Characteristics of patients with allergic polysensitization: The POLISMAIL study. Eur Ann Allergy Clin Immunol. 40:77–83. 2008.

Shamji MH and Durham SR: Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 140:1485–1498. 2017. View Article : Google Scholar

Daigle BJ and Rekkerth DJ: Practical recommendations for mixing allergy immunotherapy extracts. Allergy Rhinol (Providence). 6:1–7. 2015. View Article : Google Scholar : PubMed/NCBI

Bahceciler NN, Galip N and Cobanoglu N: Multiallergen-specific immunotherapy in polysensitized patients: Where are we? Immunotherapy. 5:183–190. 2013. View Article : Google Scholar : PubMed/NCBI

Chruszcz M, Kapingidza AB, Dolamore C and Kowal K: A robust method for the estimation and visualization of IgE cross-reactivity likelihood between allergens belonging to the same protein family. PLoS One. 13:e02082762018. View Article : Google Scholar : PubMed/NCBI

Dodig S and Čepelak I: The potential of component-resolved diagnosis in laboratory diagnostics of allergy. Biochem Med (Zagreb). 28:0205012018. View Article : Google Scholar : PubMed/NCBI

Treudler R and Simon JC: Overview of component resolved diagnostics. Curr Allergy Asthma Rep. 13:110–117. 2013. View Article : Google Scholar : PubMed/NCBI

Ebo DG: Component-resolved allergy diagnosis: A new era? Verh K Acad Geneeskd Belg. 73:163–179. 2011.PubMed/NCBI

Valenta R, Campana R, Marth K and van Hage M: Allergen-specific immunotherapy: From therapeutic vaccines to prophylactic approaches. J Intern Med. 272:144–157. 2012. View Article : Google Scholar : PubMed/NCBI

Luengo O and Cardona V: Component resolved diagnosis: When should it be used? Clin Transl Allergy. 4:282014. View Article : Google Scholar : PubMed/NCBI

Alessandri C, Ferrara R, Bernardi ML, Zennaro D, Tuppo L, Giangrieco I, Tamburrini M, Mari A and Ciardiello MA: Diagnosing allergic sensitizations in the third millennium: Why clinicians should know allergen molecule structures. Clin Transl Allergy. 7:212017. View Article : Google Scholar : PubMed/NCBI

Marth K, Focke-Tejkl M, Lupinek C, Valenta R and Niederberger V: Allergen peptides, recombinant allergens and hypoallergens for allergen-specific immunotherapy. Curr Treat Options Allergy. 1:91–106. 2014. View Article : Google Scholar : PubMed/NCBI

Curin M, Garib V and Valenta R: Single recombinant and purified major allergens and peptides: How they are made and how they change allergy diagnosis and treatment. Ann Allergy Asthma Immunol. 119:201–209. 2017. View Article : Google Scholar

Gaur SN: Future modalities in allergen immunotherapy: A brief overview. Indian J Allergy Asthma Immunol. 32:43–46. 2018. View Article : Google Scholar

Vrtala S, Focke-Tejkl M, Swoboda I, Kraft D and Valenta R: Strategies for converting allergens into hypoallergenic vaccine candidates. Methods. 32:313–320. 2004. View Article : Google Scholar : PubMed/NCBI

Valenta R, Campana R, Focke-Tejkl M and Niederberger V: Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol. 137:351–357. 2016. View Article : Google Scholar

Larsen JN and Dreborg S: Standardization of allergen extracts. Methods Mol Med. 138:133–145. 2008. View Article : Google Scholar : PubMed/NCBI

Akdis CA, Blesken T, Akdis M, Wuthrich B and Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest. 102:98–106. 1998. View Article : Google Scholar

Levy BD: Resolvin D1 and Resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways. Front Immunol. 3:3902012. View Article : Google Scholar

Lotfi R, Rezaiemanesh A, Mortazavi SH, Karaji AG and Salari F: Immunoresolvents in asthma and allergic diseases: Review and update. J Cell Physiol. 234:8579–8596. 2019. View Article : Google Scholar

Kim N, Ramon S, Thatcher TH, Woeller CF, Sime PJ and Phipps RP: Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. Eur J Immunol. 46:81–91. 2016. View Article : Google Scholar

Karra L, Haworth O, Priluck R, Levy BD and Levi-Schaffer F: Lipoxin B₄ promotes the resolution of allergic inflammation in the upper and lower airways of mice. Mucosal Immunol. 8:852–862. 2015. View Article : Google Scholar

Flesher RP, Herbert C and Kumar RK: Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma. Clin Sci (Lond). 126:805–814. 2014. View Article : Google Scholar : PubMed/NCBI

Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, Kazani S, Israel E, Haley KJ and Serhan CN: Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol. 178:496–502. 2007. View Article : Google Scholar

Krishnamoorthy N, Burkett PR, Dalli J, Abdulnour RE, Colas R, Ramon S, Phipps RP, Petasis NA, Kuchroo VK, Serhan CN and Levy BD: Cutting edge: Maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol. 194:863–867. 2015. View Article : Google Scholar

Zaiss DM, Minutti CM and Knipper JA: Immune- and non-immune-mediated roles of regulatory T-cells during wound healing. Immunology. 157:190–197. 2019. View Article : Google Scholar : PubMed/NCBI

Di Bona D, Plaia A, Scafidi V, Leto-Barone MS and Di Lorenzo G: Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A systematic review and meta-analysis. J Allergy Clin Immunol. 126:558–566. 2010. View Article : Google Scholar

Harrison OJ and Powrie FM: Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol. 5:a0183412013. View Article : Google Scholar

de Chaisemartin L: Lymphocyte Homing and Trafficking. Encyclopedia of Inflammatory Diseases. Parnham M: Birkhäuser; Basel: pp. 1–8. 2013, View Article : Google Scholar

De Calisto J, Villablanca EJ, Wang S, Bono MR, Rosemblatt M and Mora JR: T-cell homing to the gut mucosa: General concepts and methodological considerations. Methods Mol Biol. 757:411–434. 2012. View Article : Google Scholar

Weinberg EG: The WAO white book on allergy 2011–2012. Curr Allergy Clin Immunol. 24:156–157. 2011.

Ansotegui IJ, Melioli G, Canonica GW, Caraballo L, Villa E, Ebisawa M, Passalacqua G, Savi E, Ebo D, Gómez RM, et al: IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 13:1000802020. View Article : Google Scholar : PubMed/NCBI

Pitsios C, Demoly P, Bilò MB, Gerth van Wijk R, Pfaar O, Sturm GJ, Rodriguez del Rio P, Tsoumani M, Gawlik R, Paraskevopoulos G, et al: Clinical contraindications to allergen immunotherapy: An EAACI position paper. Allergy. 70:897–909. 2015. View Article : Google Scholar : PubMed/NCBI

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, et al: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part II. J Eur Acad Dermatol Venereol. 32:850–878. 2018. View Article : Google Scholar

Lommatzsch M: Current asthma treatment in light of new asthma guidelines. Dtsch Med Wochenschr. 143:806–810. 2018.(In German). View Article : Google Scholar : PubMed/NCBI

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, et al: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. J Eur Acad Dermatol Venereol. 32:657–682. 2018. View Article : Google Scholar